Abstract
Mesenchymal stem cells have gained popularity in cell-based therapies due to their regenerative capabilities, immunomodulation properties, and paracrine activity through trophic factors. It is of utmost importance to establish clinical-grade procedures for the preparation of the mesenchymal stem cells for clinical applications. Here, we describe detailed procedures for isolation, culture, cryopreservation, and preparation of mesenchymal stem cells derived from umbilical cord as a final product under good manufacturing practices–compliant conditions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Gálvez P, Clares B, Hmadcha A, Ruiz A, Soria B (2013) Development of a cell-based medicinal product: regulatory structures in the European Union. Br Med Bull 105:85–105. https://doi.org/10.1093/bmb/lds036
Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien M (2017) Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev 23:515–528. https://doi.org/10.1089/ten.teb.2016.0365
Pittenger MF (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147. https://doi.org/10.1126/science.284.5411.143
Figueroa FE, Carrión F, Villanueva S, Khoury M (2012) Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review. Biol Res 45:269–277. https://doi.org/10.4067/S0716-97602012000300008
Weiss ARR, Dahlke MH (2019) Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol 10:1191. https://doi.org/10.3389/fimmu.2019.01191
Murphy MB, Moncivais K, Caplan AI (2013) Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 45:e54. https://doi.org/10.1038/emm.2013.94
Izeta A et al (2016) Cell-based product classification procedure: what can be done differently to improve decisions on borderline products? Cytotherapy 18:809–815. https://doi.org/10.1016/j.jcyt.2016.03.292
Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004
Bedford P, Jy J, Collins L, Keizer S (2018) Considering cell therapy product ‘good manufacturing practice’ status. Front Med 5:118. https://doi.org/10.3389/fmed.2018.00118
Karumbayaram S et al (2012) From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols. Stem Cells Transl Med 1:36–43. https://doi.org/10.5966/sctm.2011-0001
Giancola R, Bonfini T, Iacone A (2012) Cell therapy: cGMP facilities and manufacturing. Muscles Ligaments Tendons J 2:243–247
Sekiya EJ, Forte A, de Bellis Kühn TIB, Janz F, Bydlowski SP, Alves A (2012) Establishing a stem cell culture laboratory for clinical trials. Rev Bras Hematol Hemoter 34:236–241. https://doi.org/10.5581/1516-8484.20120057
Whyte W (2010) Cleanroom technology : fundamentals of design, testing and operation. Wiley, Hoboken
De Sousa PA et al (2016) Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application. Stem Cell Res 17:379–390. https://doi.org/10.1016/j.scr.2016.08.011
Lv F-J, Tuan RS, Cheung KMC, Leung VYL (2014) Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 32:1408–1419. https://doi.org/10.1002/stem.1681
Bieback K, Schallmoser K, Klüter H, Strunk D (2008) Clinical protocols for the isolation and expansion of mesenchymal stromal cells. Transfus Med Hemother 35:286–294. https://doi.org/10.1159/000141567
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media New York
About this protocol
Cite this protocol
Aydoğdu, N., Öztel, O.N., Karaöz, E. (2020). Isolation, Culture, Cryopreservation, and Preparation of Umbilical Cord-Derived Mesenchymal Stem Cells as a Final Cellular Product Under Good Manufacturing Practices–Compliant Conditions. In: Turksen, K. (eds) Stem Cells and Good Manufacturing Practices. Methods in Molecular Biology, vol 2286. Humana, New York, NY. https://doi.org/10.1007/7651_2020_332
Download citation
DOI: https://doi.org/10.1007/7651_2020_332
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1326-9
Online ISBN: 978-1-0716-1327-6
eBook Packages: Springer Protocols